U.S. Healthtech Stock News

In recent months, Deluxe has drawn renewed attention as its Data Solutions business benefits from accelerating adoption of digital operations by financial institutions and small and medium-sized enterprises. This shift highlights the company’s growing exposure to higher-quality, recurring technology revenues while its traditional print products remain under pressure from digital alternatives. We’ll now examine how the strong momentum in Deluxe’s Data Solutions segment may reshape the...

In February 2026, Navios Maritime Partners L.P. reported fourth-quarter 2025 results showing higher sales of US$365.55 million and net income of US$117.33 million year over year, alongside a 20% increase in its quarterly distribution to US$0.06 per unit and completion of a buyback covering 5.45% of its units. While full-year 2025 net income of US$285.33 million and earnings per unit eased compared with the prior year, the combination of stronger quarterly performance, higher distributions,...

Why Denali Therapeutics Stock Is Back in Focus Denali Therapeutics (DNLI) is drawing fresh attention after reporting a wider net loss for the fourth quarter and full year, along with a new common stock shelf registration that signals possible future share issuance. See our latest analysis for Denali Therapeutics. At a share price of US$21.18, Denali’s short term momentum has been mixed, with a 4.9% 7 day share price return alongside a 16.63% 90 day share price return and a 30.18% year to date...

Centerspace (CSR) drew fresh attention after releasing fourth quarter and full year 2025 results, issuing 2026 earnings guidance that points to a net loss, and reaffirming its quarterly dividend payout. See our latest analysis for Centerspace. The latest earnings update and guidance arrived after a stretch where the 1 year total shareholder return was roughly flat at 0.05%, even as the share price return year to date declined 6.08%. This hints that momentum has softened despite dividends...

In February 2026, Portland General Electric reported full-year 2025 revenue of US$3,576 million and net income of US$306 million, while also disclosing lower earnings per share than the prior year. On the same day, the company completed a roughly US$480 million follow-on common stock offering, signaling a major capital raise that meaningfully alters its equity base and funding mix. We’ll now examine how this substantial equity issuance may influence Portland General Electric’s investment...

Daqo New Energy (DQ) stock is back in focus after the company released Q4 2025 results alongside fresh 2026 production guidance, combining its first positive EBITDA in six quarters with continued net losses. See our latest analysis for Daqo New Energy. At a share price of US$24.12, Daqo New Energy has a 1 year total shareholder return of 19.11%. However, the 3 year and 5 year total shareholder returns of 53.63% and 69.84% declines show that longer term momentum has been weak, despite the...

Innoviva, Inc. recently reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, capping a full year in which revenue reached US$411.33 million and net income climbed to US$271.17 million. These results highlight the growing weight of the Innoviva Specialty Therapeutics platform in the business, alongside the U.S. FDA approval of NUZOLVENCE®, which together reinforce the company’s shift from a royalty-focused model toward a broader commercial portfolio...

In February 2026, BioLife Solutions, Inc. reported fourth-quarter 2025 sales of US$24.76 million, full-year 2025 sales of US$96.21 million, a reduced full-year net loss of US$4.60 million, and issued 2026 revenue guidance of US$112.5 million to US$115.0 million alongside an expectation of GAAP net income for the year. Management highlighted that growth was primarily driven by its biopreservation media franchise, now embedded in multiple approved cell and gene therapies, supported by a...

Enact Holdings (ACT) has drawn fresh attention after authorizing a US$350 million share repurchase program and securing a new US$435 million revolving credit facility, alongside an analyst upgrade to Strong Buy. See our latest analysis for Enact Holdings. The recent buyback authorization, new revolving credit facility and earnings upgrade come after a steady 30 day share price return of 5.20% and a 1 year total shareholder return of 24.39%, while the 3 year total shareholder return of 87.86%...

In February 2026, Bell Cyber and Radware expanded their partnership to launch an AI-driven, cloud-delivered security service that combines Radware’s application and API protection with Bell Cyber’s fully managed security operations for organizations across Canada and the U.S. A key feature of the new offering is its Canadian-managed operations model, which aims to meet data sovereignty and compliance needs while giving customers a single, consolidated platform for web, API, bot, and DDoS...

Arcos Dorados Holdings (NYSE:ARCO) has closed a long standing shelf registration covering 5,238,235 Class A shares linked to an employee stock ownership plan, an event that puts its capital structure moves back in focus. See our latest analysis for Arcos Dorados Holdings. The shelf registration closure comes after a period of solid trading momentum, with Arcos Dorados showing a 30-day share price return of 7.58%, a year-to-date share price return of 20.71%, and a 1-year total shareholder...

DRDGOLD (DRD) is back in focus after reporting half year earnings to December 31, 2025, with sales of ZAR 5,053.2 million and net income of ZAR 1,927.7 million. See our latest analysis for DRDGOLD. Those half year results land after a very strong run, with a 30 day share price return of 22.25% and a 90 day share price return of 29.62% pointing to building momentum. Meanwhile, the 1 year total shareholder return of 259.34% and 3 year total shareholder return of about 4.7x highlight how...

In February 2026, Seadrill Limited reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$362 million for the quarter and US$1.44 billion for the year, but a net loss of US$10 million for the quarter and US$77 million for the year, including a US$22 million impairment on long-lived assets. Despite the headline loss, Seadrill highlighted record safety performance, strong EBITDA of US$353 million, new and extended contracts, and issued 2026 revenue guidance of...

Anywhere Real Estate Inc. has released its full-year 2025 results, reporting revenue of US$5,960 million compared with US$5,692 million in 2024, and a net loss of US$90 million versus US$128 million previously. The combination of higher revenue and a smaller net loss points to operational progress that investors may see as a sign of improving financial health, even though the business remains loss-making. We’ll now examine how this revenue growth and reduced net loss might reshape Anywhere...

Parker-Hannifin (NYSE:PH) reports record-level margins following the integration of Meggitt into its aerospace operations. The company highlights stronger than expected synergies from Meggitt and new efficiency gains across its portfolio. A pending acquisition of Filtration Group is set to extend these efforts and reshape Parker-Hannifin's filtration and aerospace exposure. Parker-Hannifin, trading at about $1,009.18 per share, is coming off a strong multi year run, with the stock up 56.6%...

Science Applications International Corp. has recently secured a US$95 million contract from the U.S. Government Accountability Office to modernize its Technical Information Services program with end-to-end IT solutions and a more secure, data-driven infrastructure. By embedding security, automation, and agile delivery into GAO’s technology stack, SAIC is positioning itself as a key partner in federal IT modernization and complex digital engineering projects. Next, we’ll examine how this GAO...

In recent days, Citigroup has been very active in capital markets, filing an omnibus shelf registration and issuing a wide range of senior and subordinated fixed‑rate and zero‑coupon notes across maturities from 2028 to 2056, while also closing the sale of its Russian operations, which added about US$4.00 billion to its Common Equity Tier 1 capital. At the same time, Citigroup is pushing further into digital finance by planning to integrate Bitcoin into its core banking systems by 2026,...

Recent enthusiasm around Synaptics (SYNA) has centered on stronger reported revenue, higher guidance, and its push into Edge AI and wireless, supported by the earlier purchase of Broadcom’s Wi Fi assets. See our latest analysis for Synaptics. At a share price of US$81.46, Synaptics has seen a 14.88% 90 day share price return and a 29.49% 1 year total shareholder return. This suggests momentum is building as investors react to stronger revenue, higher guidance, insider selling activity, and...

Cboe Global Markets (CBOE) is on investors’ radar after reporting record Q4 and full year 2025 results, with strong derivatives revenue and options momentum helping push the stock to an all time high. See our latest analysis for Cboe Global Markets. The earnings release has capped an eight day winning streak for Cboe Global Markets. The 30 day share price return of 13.08% and year to date share price return of 20.80% point to strong upside momentum, while the 1 year total shareholder return...

Omnicell (OMCL) is drawing fresh investor attention after its shift toward software and services was underscored by the ANiGENT acquisition, a move that centers on drug diversion detection and recurring revenue potential. See our latest analysis for Omnicell. While Omnicell’s latest software-focused move has caught attention, the share price tells a mixed story, with a 90 day share price return of 13.79% contrasting with a 5 year total shareholder return decline of 66.95%, suggesting recent...

In late February 2026, LifeStance Health Group reported fourth-quarter 2025 revenue of US$382.2 million and net income of US$11.7 million, issued 2026 revenue guidance of US$1.615 billion to US$1.655 billion, authorized a US$100 million share repurchase plan, and filed follow-on and shelf registrations for new common stock offerings. Together, the return to profitability, expanded capital markets activity, and planned buybacks highlight how LifeStance is actively reshaping its balance...

Hercules Capital (HTGC) came under pressure after a Hunterbrook short report questioned its software debt valuations and dividend sustainability, while hotter inflation data and reduced rate cut hopes added further selling pressure to the stock. See our latest analysis for Hercules Capital. The short report and hotter inflation data have hit recent momentum hard, with a 1-day share price return of a 7.91% decline and a 30-day share price return of a 23.31% decline, while the 5-year total...

Why Ally Financial Stock Reacted to the Inflation Surprise The higher-than-expected Producer Price Index reading, which reduced hopes for near-term rate cuts, triggered a broad sell-off in financials and pushed Ally Financial (ALLY) shares down 6.3%. See our latest analysis for Ally Financial. Beyond the inflation shock, Ally Financial’s 1 day share price return of 6% capped a weaker short term patch. However, its 1 year total shareholder return of 15.7% and 3 year total shareholder return of...

In late February 2026, Triumph Financial, Inc.’s board declared a quarterly cash dividend of US$17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, with holders of NYSE-listed depositary shares receiving US$0.44525 per share payable on March 30, 2026 to investors of record on March 15, 2026. This routine preferred dividend, alongside fresh inflation data that may influence Federal Reserve policy, highlights the contrast between Triumph’s capital return...